Onco Wiki / Maladie

Waldenström Macroglobulinémie / Lymphome lymphoplasmacytique

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDDIS-WM
TypeMaladie
Alias
LPLWMМакроглобулінемія Вальденстрема / Лімфоплазмоцитарна лімфома
Étatreviewed 2026-04-25 | pending_clinical_signoff
MaladiesAucune déclaration
SourcesSRC-NCCN-BCELL-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology9671/3
icd_10C88.0
who_classificationMature B-cell neoplasms — Lymphoplasmacytic lymphoma per WHO 5th ed.

Capacités

Notes

Only NHL with defining "must-have" mutation (MYD88 L265P) — strongly predicts BTKi response. CXCR4 status affects BTKi depth of response (WT > WHIM-mutated). Hyperviscosity emergency requires plasmapheresis before any cytotoxic therapy.

Utilisé par

Pertinence thérapeutique

Algorithmes

Indication

Questionnaires

Signal d’alerte

Sources